Subscribe
shutterstock_685347493_katherine_welles
Katherine Welles / Shutterstock.com
25 June 2019Americas

Cancer centre sues BMS and Ono over alleged patent exploitation

Boston-based Dana-Farber Cancer Institute is seeking a share of the $1.6 billion in licensing revenue that BMS and Ono Pharmaceutical Co have allegedly received from six immunotherapy patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Bristol-Myers Squibb hits Merck with cancer patent lawsuit
10 September 2014   Bristol-Myers Squibb has accused pharmaceutical company Merck of infringing a patent covering a method used to treat cancer.
Big Pharma
Ono sues AstraZeneca over antibody patents
1 March 2022   Japan-based Ono Pharmaceuticals has sued AstraZeneca, accusing the US pharma company of infringing patents covering an antibody used in cancer treatment.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Bristol-Myers Squibb hits Merck with cancer patent lawsuit
10 September 2014   Bristol-Myers Squibb has accused pharmaceutical company Merck of infringing a patent covering a method used to treat cancer.
Big Pharma
Ono sues AstraZeneca over antibody patents
1 March 2022   Japan-based Ono Pharmaceuticals has sued AstraZeneca, accusing the US pharma company of infringing patents covering an antibody used in cancer treatment.

More on this story

Americas
Bristol-Myers Squibb hits Merck with cancer patent lawsuit
10 September 2014   Bristol-Myers Squibb has accused pharmaceutical company Merck of infringing a patent covering a method used to treat cancer.
Big Pharma
Ono sues AstraZeneca over antibody patents
1 March 2022   Japan-based Ono Pharmaceuticals has sued AstraZeneca, accusing the US pharma company of infringing patents covering an antibody used in cancer treatment.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool